Settlement Agreements in the Pharmaceuticals Industry

195 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (1 contract)
Acasti Pharma Inc. (1)
Adamis Pharmaceuticals Corp (1)
ADIAL PHARMACEUTICALS, INC. (2)
AEON Biopharma, Inc. (1)
Akers Biosciences, Inc. (1)
Akorn (2)
ALDER BIOPHARMACEUTICALS INC (1)
Amag Pharmaceuticals (2)
Anacor Pharmaceuticals, Inc. (1)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (1)
Aspreva Pharmaceuticals CORP (1)
Assertio Therapeutics, Inc (3)
AVANIR PHARMACEUTICALS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (1)
BARR PHARMACEUTICALS INC (2)
Bausch Health Companies Inc. (1)
BENTLEY PHARMACEUTICALS INC (1)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (1)
Biofrontera Inc. (5)
BODY & MIND INC. (3)
Boston Therapeutics, Inc. (1)
Bright Green Corp (1)
CADENCE PHARMACEUTICALS INC (2)
Canbiola, Inc. (2)
CANNAPHARMARX, INC. (3)
Catalent Inc (1)
COLLEGIUM PHARMACEUTICAL, INC (1)
ContraVir Pharmaceuticals, Inc. (1)
COSMO VENTURES INC (3)
CUBIST PHARMACEUTICALS INC (1)
Cure Pharmaceutical Holding Corp. (0)
Dermata Therapeutics, Inc. (2)
DUSA PHARMACEUTICALS INC (1)
ELITE PHARMACEUTICALS INC (1)
Endexx Corp (1)
Endo International plc (2)
Evolus, Inc. (3)
EYENOVIA, INC. (1)
GB SCIENCES INC (2)
GRAYBUG VISION, INC. (1)
GREEN HYGIENICS HOLDINGS INC. (5)
HARROW HEALTH, INC. (2)
Haymaker Acquisition Corp. III (2)
Horizon Pharma plc (7)
IDENIX PHARMACEUTICALS INC (1)
IMAGING3 INC (2)
Jaguar Health, Inc. (4)
Jazz Pharmaceuticals plc (5)
Johnson & Johnson (1)
JUNIPER PHARMACEUTICALS INC (1)
Kala Pharmaceuticals, Inc. (1)
Kannalife Inc (1)
KING PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Lexaria Bioscience Corp. (2)
Lilly (Eli) & Co. (2)
Mallinckrodt (2)
Medicine Man Technologies, Inc. (1)
MICROCHANNEL TECHNOLOGIES CORP (1)
MJ Holdings, Inc. (3)
Mylan N.V. (1)
MYnd Analytics, Inc. (1)
NEKTAR THERAPEUTICS (1)
Neos Therapeutics, Inc. (2)
NewBridge Global Ventures, Inc. (17)
Notis Global, Inc. (1)
OMEROS CORP (4)
Osmotica Pharmaceuticals plc (1)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (1)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (2)
Pivot Pharmaceuticals Inc. (2)
PLAYERS NETWORK (1)
PRAECIS PHARMACEUTICALS INC (1)
Processa Pharmaceuticals, Inc. (1)
ProPhase Labs, Inc. (1)
RADIENT PHARMACEUTICALS Corp (3)
Reliant Pharmaceuticals, Inc. (2)
RELMADA THERAPEUTICS, INC. (1)
RespireRx Pharmaceuticals Inc. (5)
Sagent Pharmaceuticals, Inc. (1)
SALIX PHARMACEUTICALS LTD (1)
SCYNEXIS INC (1)
SenesTech, Inc. (1)
Sucampo Pharmaceuticals, Inc. (2)
Supernus Pharmaceuticals, Inc. (3)
TAURIGA SCIENCES, INC. (2)
Terra Tech Corp. (3)
TEVA PHARMACEUTICAL INDUSTRIES LTD (3)
Textmunication Holdings, Inc. (5)
Theravance Biopharma, Inc. (2)
TITAN PHARMACEUTICALS INC (2)
VASO ACTIVE PHARMACEUTICALS INC (1)
VIA Pharmaceuticals, Inc. (1)
Virpax Pharmaceuticals, Inc. (1)
VIVUS INC (2)
WEED, INC. (1)
ZOGENIX, INC. (1)

Recent Contracts

Settlement Agreement and Release of Claims, dated August 12, 2024, between the Company and Streeterville Capital, LLC (Big Rock Partners Acquisition Corp., Filed With SEC on August 14, 2024)
Settlement Agreement between the Company and Marci M. Donovitz, dated June 28, 2024 (Haymaker Acquisition Corp. III, Filed With SEC on August 9, 2024)
Settlement Agreement, dated as of April 30, 2024, by and between Supernus Pharmaceuticals, Inc. and Ascent Pharmaceuticals, Inc (Supernus Pharmaceuticals, Inc., Filed With SEC on August 6, 2024)
English summary of Tax Settlement Agreement, dated June 23, 2024, between Teva Pharmaceutical Industries Limited and the Israeli Tax Authorities (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on July 31, 2024)
Settlement Agreement between the Company and Dr. Gary S. Donovitz, dated April 23, 2024 (Haymaker Acquisition Corp. III, Filed With SEC on May 10, 2024)
Form of Settlement Agreement and General and Mutual Release between the Company and each of Eric Greenberg, Matthew C. McMurdo and David Natan (TITAN PHARMACEUTICALS INC, Filed With SEC on April 3, 2024)
Settlement Agreement and Release dated March 13, 2024 (Bright Green Corp, Filed With SEC on March 19, 2024)
Civil Settlement Agreement, dated February 20, 2024, among the United States, Endo Health Solutions Inc. and Loretta Reed (Endo International plc, Filed With SEC on March 6, 2024)
Global Settlement Agreement, dated February 28, 2024, by and among the United States of America, Endo Inc. and Endo International PLC (Endo International plc, Filed With SEC on March 6, 2024)
Settlement Agreement and Mutual Release between Virpax Pharmaceuticals, Inc. and Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals Inc (Virpax Pharmaceuticals, Inc., Filed With SEC on March 1, 2024)
Settlement Agreement, dated as of June 21, 2023, by and between Supernus Pharmaceuticals, Inc. with Apotex Inc. and Apotex Corp (Supernus Pharmaceuticals, Inc., Filed With SEC on February 27, 2024)
Settlement Agreement and Release, dated February 20, 2024, by and between the Company and Nirup Krishnamurthy (Medicine Man Technologies, Inc., Filed With SEC on February 23, 2024)
Debt Settlement Agreement in the amount of $54,000 dated January 30, 2024 related to Former Officer Noted dated on or about April 10, 2018 (RespireRx Pharmaceuticals Inc., Filed With SEC on February 2, 2024)
Debt Settlement Agreement in the amount of $40,500 dated January 30, 2024 related to Former Officer Noted dated on or about September 22, 2016 (RespireRx Pharmaceuticals Inc., Filed With SEC on February 2, 2024)
Debt Settlement Agreement in the amount of $85,500 dated January 30, 2024 related to Former Officer Noted dated on or about February 2, 2016 (RespireRx Pharmaceuticals Inc., Filed With SEC on February 2, 2024)
Confidential Settlement Agreement and Mutual Release, dated as of December 27, 2023 and effective as of December 22, 2023, by and between the Company and Maruho (Biofrontera Inc., Filed With SEC on January 3, 2024)
Settlement Agreement, dated October 18, 2023, by and between the Company and Aker BioMarine Antarctic AS (Acasti Pharma Inc., Filed With SEC on October 23, 2023)
Amendment No. 1 to Settlement Agreement dated as of October 12, 2023, between Biofrontera Inc., Hermann Luebbert, John J. Borer, Loretta M. Wedge, Beth J. Hoffman, Kevin D. Weber... (Biofrontera Inc., Filed With SEC on October 13, 2023)
Settlement Term Sheet, dated as of October 4, 2023, between RVL Pharmaceuticals, Inc. and the Sellers (Osmotica Pharmaceuticals plc, Filed With SEC on October 13, 2023)
Settlement Agreement with MKC Development Group, LLC dated May 24, 2023 (MJ Holdings, Inc., Filed With SEC on August 14, 2023)
Confidential Settlement and General Release Agreement, dated as of May 25, 2023, between the Company and Erica Monaco (Biofrontera Inc., Filed With SEC on August 11, 2023)
Teva Global Opioids Settlement Agreement, effective on August 7, 2023, between Teva Pharmaceutical Industries Ltd. and the states, subdivisions and special districts named therein (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on August 2, 2023)
Settlement Agreement dated April 11, 2023 between Biofrontera Inc., Hermann Luebbert, John J. Borer, Loretta M. Wedge, Beth J. Hoffman, Kevin D. Weber and Biofrontera AG (Biofrontera Inc., Filed With SEC on May 12, 2023)
Settlement Agreement between the Company, NCMM, LLC and Valerie Small dated March 31, 2023 (MJ Holdings, Inc., Filed With SEC on May 5, 2023)
Settlement Agreement and Release, dated April 30, 2023 (Terra Tech Corp., Filed With SEC on May 4, 2023)
Settlement Agreement, dated as of December 31, 2022, by and between Supernus Pharmaceuticals, Inc., Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited (Supernus Pharmaceuticals, Inc., Filed With SEC on March 9, 2023)
Settlement Agreement and Release of Claims by and between Andrew Hindman and Theravance Biopharma US, Inc., dated January 10, 2023 (Theravance Biopharma, Inc., Filed With SEC on March 1, 2023)
SETTLEMENT AGREEMENT (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on January 27, 2023)
Settlement Agreement, dated as of April 5, 2017, by and between Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, and Roxane Laboratories, Inc., West-Ward... (Jazz Pharmaceuticals plc, Filed With SEC on November 9, 2022)
Form of Settlement, Lock-Up, and Leak-Out Agreement between the registrant and seven separate investors, effective August 31, 2022 (Endexx Corp, Filed With SEC on September 7, 2022)
Settlement Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company (Petros Pharmaceuticals, Inc., Filed With SEC on May 16, 2022)
Amended Settlement Allocation Agreement dated as of March 31, 2022 between the Company and Biofrontera AG (Biofrontera Inc., Filed With SEC on April 5, 2022)
Settlement Agreement, dated as of March 7, 2022, among the United States of America, acting through the United States Department of Justice and on behalf of the Office of... (Mallinckrodt, Filed With SEC on March 11, 2022)
Settlement Agreement, dated as of March 7, 2022, among the United States of America, acting through the United States Department of Justice and on behalf of the Office of... (Mallinckrodt, Filed With SEC on March 11, 2022)
Settlement Agreement by and between Ann Brady and Theravance Biopharma Ireland Limited, dated November 2, 2021 (Theravance Biopharma, Inc., Filed With SEC on February 28, 2022)
Settlement Agreement, dated as of February 4, 2022 (EYENOVIA, INC., Filed With SEC on February 7, 2022)
Settlement Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company (Petros Pharmaceuticals, Inc., Filed With SEC on January 21, 2022)
Settlement Agreement between the Company, US Compounding Inc., Nephron Pharmaceuticals Corporation, Nephron S.C., Inc., Nephron Sterile Compounding Center, LLC and certain other... (Adamis Pharmaceuticals Corp, Filed With SEC on November 22, 2021)
Settlement and License Agreement dated June 21, 2021 by and between the Registrant and Medytox, Inc (AEON Biopharma, Inc., Filed With SEC on September 17, 2021)
Amendment to the License Amendment and Settlement Agreement between Dermata Therapeutics, Inc. and Villani, Inc., dated July 30, 2021 (Dermata Therapeutics, Inc., Filed With SEC on August 6, 2021)